Where do things currently stand in the FDA approval process?
Dr. Sanders: We just got a grant for just under a million dollars to develop the rapid point of care and we are just submitting a grant for the Department of Defense to make the band-aid change color if you have an infection. We are now working with an engineering firm to make the design housings for the point of care and then we are going to draw our last set of clinical trials that would then get submitted to the FDA for express detect and RDD — rapid diagnostic approval. When do you expect this to be on the market? Dr. Sanders: Probably in a year and a half, you will start to see our products on the shelf. If you see express detect, it’s simple, its inexpensive, and it’s a rapid diagnostic for infection. What is the status of the clinical trials? Dr. Sanders: About 250 patients will be working with hospitals at U Mass and also we have a lot of engineers at WPI that work here, as well, but we have another clinic set up at U Penn and we will do clinical testing around the country the
